Activation of Nrf2 Signaling by Apelin Attenuates Renal Ischemia Reperfusion Injury in Diabetic Rats
Overview
Authors
Affiliations
Objective: Renal ischemia/reperfusion (I/R) injury is commonly seen in diabetic patients. Apelin has been demonstrated to protect against renal I/R injury, whereas detailed modulatory mechanisms by which Apelin exerts its role in renal I/R injury in diabetic patients remain unclarified. This research aimed to probe the functional molecules under the regulation of Apelin in renal I/R injury in diabetic rats.
Materials And Methods: First, animal models were established for subsequent assays. Biochemical kits measured the serum levels of blood urea nitrogen (BUN) and serum creatinine (SCR), and hematoxylin and eosin (H&E) staining examined the histopathological changes of kidney tissues. Inflammatory factors containing tumor necrosis factor alpha (TNF-α), interleukin 1β (IL-1β), interleukin 6 (IL-6) and monocyte chemoattractant protein-1 (MCP-1) were tested through enzyme-linked immunosorbent assay (ELISA) and reverse transcription-quantitative polymerase chain reaction (RT-qPCR), respectively. Reactive oxygen species (ROS) levels in the serum and kidney tissues were separately assessed by specific ROS kits. Cell apoptosis was further estimated through terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) and Western blot analysis. Eventually, the influences of Apelin on nuclear factor erythroid 2-related factor (Nrf2) and its downstream genes were explored via Western blot analysis and immunohistochemistry (IHC).
Results: In the present study, Apelin ameliorated the damage to renal function and histological structure, decreased levels of inflammatory factors and ROS, and hampered cell apoptosis in renal I/R injury of diabetic rats. Moreover, Apelin could elevate the levels of Nrf2 and downstream genes which were decreased under renal I/R injury.
Conclusion: These data indicated that Apelin inhibited renal I/R injury through regulating Nrf2 signaling in diabetic rats, which might shed new light on the treatment of renal I/R injury in diabetic patients.
Effects of apelin on neonatal brain neurogenesis in L-NAME-induced maternal preeclampsia.
Tomruk C, Sirin Tomruk C, Denizlioglu B, Olukman M, Ercan G, Duman S Sci Rep. 2024; 14(1):19347.
PMID: 39164321 PMC: 11335761. DOI: 10.1038/s41598-024-69326-2.
Chen K, Ou B, Huang Q, Deng D, Xiang Y, Hu F Epigenetics. 2024; 19(1):2293409.
PMID: 38232183 PMC: 10795783. DOI: 10.1080/15592294.2023.2293409.
Guo X, Lei M, Ma G, Ouyang C, Yang X, Liu C Mol Neurobiol. 2023; 61(5):2514-2529.
PMID: 37910285 DOI: 10.1007/s12035-023-03725-w.
Allicin ameliorates sepsis-induced acute kidney injury through Nrf2/HO-1 signaling pathway.
Li X, Liu T, Wang Y J Nat Med. 2023; 78(1):53-67.
PMID: 37668824 PMC: 10764392. DOI: 10.1007/s11418-023-01745-3.
Rossin D, Vanni R, Lo Iacono M, Cristallini C, Giachino C, Rastaldo R Pharmaceutics. 2023; 15(5).
PMID: 37242650 PMC: 10223849. DOI: 10.3390/pharmaceutics15051408.